Is Rigel Pharmaceuticals, Inc. (RIGL) a Buy, Sell, or Hold?
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
$41.18 USD
$0.01 (0.02%)
- Volume
- 221.59K
- Average Volume
- 395.74K
- Market Capitalization
- $761.92M
- P/E Ratio
- 2.05
- Dividend Yield
- 0.00%
- Price Target
- $38.00
- Year High
- $52.24
- Year Low
- $18.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.62
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
32
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
26
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$190.76K
RIGL Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
RIGL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| HANNAH ALISON L. | officer: EVP, Chief Medical Officer | 2026-07-08 | A-Award | 0 | 2026-07-10 |
| Ali-Jackson Kamil | director | 2026-06-22 | S-Sale | 35 | 2026-06-24 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2026-06-17 | A-Award | 22.49 | 2026-06-22 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-06-17 | A-Award | 22.49 | 2026-06-22 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2026-06-17 | A-Award | 14.9 | 2026-06-22 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2026-06-17 | A-Award | 22.49 | 2026-06-22 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2026-06-17 | A-Award | 22.49 | 2026-06-22 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-06-17 | A-Award | 22.49 | 2026-06-22 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-06-01 | M-Exempt | 12.7 | 2026-06-03 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-06-01 | F-InKind | 29.86 | 2026-06-03 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-06-01 | M-Exempt | 18.7 | 2026-06-03 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-06-01 | M-Exempt | 12.7 | 2026-06-03 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-06-01 | M-Exempt | 18.7 | 2026-06-03 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2026-06-01 | F-InKind | 29.86 | 2026-06-03 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2026-06-01 | F-InKind | 29.86 | 2026-06-03 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-06-01 | F-InKind | 29.86 | 2026-06-03 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2026-06-01 | F-InKind | 29.86 | 2026-06-03 |
| Ali-Jackson Kamil | director | 2026-05-26 | S-Sale | 29.17 | 2026-05-28 |
| Wasman Jane | director | 2026-05-15 | A-Award | 0 | 2026-05-19 |
| MOOS WALTER H | director | 2026-05-15 | A-Award | 0 | 2026-05-19 |
| MILLER MICHAEL PATRICK | director | 2026-05-15 | A-Award | 0 | 2026-05-19 |
| LAPOINTE ANTHONY GREGG | director | 2026-05-15 | A-Award | 0 | 2026-05-19 |
| HANNAH ALISON L. | director | 2026-05-15 | A-Award | 0 | 2026-05-19 |
| Frohlich Mark W | director | 2026-05-15 | A-Award | 0 | 2026-05-19 |
| Ali-Jackson Kamil | director | 2026-05-15 | A-Award | 0 | 2026-05-19 |
| MOOS WALTER H | director | 2026-02-20 | M-Exempt | 24 | 2026-02-24 |
| MOOS WALTER H | director | 2026-02-20 | S-Sale | 36.36 | 2026-02-24 |
| MOOS WALTER H | director | 2026-02-20 | M-Exempt | 24 | 2026-02-24 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2026-02-17 | A-Award | 0 | 2026-02-19 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-02-10 | F-InKind | 34.62 | 2026-02-12 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2026-02-10 | F-InKind | 34.62 | 2026-02-12 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2026-02-10 | F-InKind | 34.62 | 2026-02-12 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-02-10 | F-InKind | 34.62 | 2026-02-12 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2026-02-10 | F-InKind | 34.62 | 2026-02-12 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2026-02-02 | F-InKind | 36.01 | 2026-02-04 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2026-02-02 | F-InKind | 36.01 | 2026-02-04 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2026-02-02 | F-InKind | 36.01 | 2026-02-04 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-01-26 | M-Exempt | 27.4 | 2026-02-04 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-01-26 | M-Exempt | 27.4 | 2026-02-04 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-01-26 | F-InKind | 37 | 2026-02-04 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-01-26 | F-InKind | 37 | 2026-02-04 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-02-02 | F-InKind | 36.01 | 2026-02-04 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2026-01-26 | M-Exempt | 27.4 | 2026-02-04 |
| MILLER MICHAEL PATRICK | director | 2026-02-01 | A-Award | 34.86 | 2026-02-03 |
| MILLER MICHAEL PATRICK | director | 2026-02-01 | 0 | 2026-02-03 | |
| MILLER MICHAEL PATRICK | director | 2026-02-01 | 16.05 | 2026-02-03 | |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-12-22 | M-Exempt | 18.7 | 2025-12-29 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-12-22 | M-Exempt | 24.2 | 2025-12-29 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-12-22 | M-Exempt | 20 | 2025-12-29 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-12-22 | M-Exempt | 24.2 | 2025-12-29 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-12-22 | M-Exempt | 20 | 2025-12-29 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-12-22 | M-Exempt | 18.7 | 2025-12-29 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-09-15 | A-Award | 22.49 | 2025-09-17 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2025-09-15 | A-Award | 22.49 | 2025-09-17 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2025-09-15 | A-Award | 22.49 | 2025-09-17 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2025-09-15 | A-Award | 22.49 | 2025-09-17 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2025-09-15 | A-Award | 22.49 | 2025-09-17 |
| Wasman Jane | director | 2025-05-23 | A-Award | 0 | 2025-05-28 |
| Wasman Jane | director | 2025-05-23 | A-Award | 18.95 | 2025-05-28 |
| Ali-Jackson Kamil | director | 2025-05-23 | A-Award | 0 | 2025-05-28 |
| Ali-Jackson Kamil | director | 2025-05-23 | A-Award | 18.95 | 2025-05-28 |
| MOOS WALTER H | director | 2025-05-23 | A-Award | 0 | 2025-05-28 |
| MOOS WALTER H | director | 2025-05-23 | A-Award | 18.95 | 2025-05-28 |
| LAPOINTE ANTHONY GREGG | director | 2025-05-23 | A-Award | 0 | 2025-05-28 |
| LAPOINTE ANTHONY GREGG | director | 2025-05-23 | A-Award | 18.95 | 2025-05-28 |
| HANNAH ALISON L. | director | 2025-05-23 | A-Award | 0 | 2025-05-28 |
| HANNAH ALISON L. | director | 2025-05-23 | A-Award | 18.95 | 2025-05-28 |
| Frohlich Mark W | director | 2025-05-23 | A-Award | 18.95 | 2025-05-28 |
| Frohlich Mark W | director | 2025-05-23 | A-Award | 0 | 2025-05-28 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-03-17 | A-Award | 12.7 | 2025-03-19 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-03-17 | A-Award | 35.4 | 2025-03-19 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2025-03-17 | A-Award | 12.7 | 2025-03-19 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2025-03-17 | A-Award | 35.4 | 2025-03-19 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2025-03-17 | A-Award | 14.9 | 2025-03-19 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2025-03-17 | A-Award | 12.7 | 2025-03-19 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2025-03-17 | A-Award | 35.4 | 2025-03-19 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2025-03-17 | A-Award | 9 | 2025-03-19 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2025-03-17 | A-Award | 12.7 | 2025-03-19 |
| Frohlich Mark W | director | 2025-03-06 | A-Award | 19.7 | 2025-03-10 |
| Frohlich Mark W | 2025-03-06 | 0 | 2025-03-10 | ||
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-02-04 | S-Sale | 20.921 | 2025-02-06 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-02-05 | S-Sale | 21.926 | 2025-02-06 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2025-02-04 | S-Sale | 20.921 | 2025-02-06 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2025-02-05 | S-Sale | 21.926 | 2025-02-06 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2025-02-04 | S-Sale | 20.921 | 2025-02-06 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2025-02-05 | S-Sale | 21.926 | 2025-02-06 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2025-02-04 | S-Sale | 20.921 | 2025-02-06 |
| Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | 2025-02-05 | S-Sale | 21.926 | 2025-02-06 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2025-01-29 | A-Award | 0 | 2025-01-31 |
| Rojkjaer Lisa | officer: EVP, Chief Medical Officer | 2025-01-29 | A-Award | 22.49 | 2025-01-31 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2025-01-29 | A-Award | 0 | 2025-01-31 |
| RODRIGUEZ RAUL R | director, officer: CEO, President | 2025-01-29 | A-Award | 22.49 | 2025-01-31 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-01-29 | A-Award | 0 | 2025-01-31 |
| Schorno Dean L | officer: EVP & Chief Financial Officer | 2025-01-29 | A-Award | 22.49 | 2025-01-31 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2025-01-29 | A-Award | 0 | 2025-01-31 |
| Santos David A | officer: EVP, Chief Commercial Officer | 2025-01-29 | A-Award | 22.49 | 2025-01-31 |